A groundbreaking personalised cancer treatment is emerging from an unexpected location: Stevenage High Street. UK biotech firm Autolus has received FDA approval to manufacture and distribute its innovative Car-T cell
A groundbreaking personalised cancer treatment is emerging from an unexpected location: Stevenage High Street. UK biotech firm Autolus has received FDA approval to manufacture and distribute its innovative Car-T cell
Danish pharmaceutical giant Novo Nordisk witnessed a staggering $100 billion erosion in market value following disappointing results from its latest obesity drug trial. The company’s shares experienced their most significant
The United Kingdom’s weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within
In a significant development for the UK healthcare sector, the NHS has announced the introduction of a groundbreaking once-daily tablet for advanced breast cancer treatment. This strategic move is projected
In a significant move strengthening its technological capabilities, AstraZeneca has appointed Arm Holdings Chief Executive Rene Haas to its board as a non-executive director, effective from next month. The appointment
In a significant development for medical research, UK scientists are pioneering a revolutionary approach to treating rare genetic diseases through a £50 million initiative backed by the Medical Research Council.
Groundbreaking research indicates that popular weight-loss medications like Ozempic, Wegovy, and Mounjaro might have far-reaching applications beyond obesity treatment, potentially revolutionising the approach to various chronic conditions. Dr Mo Sarhan,
The US pharmacy giant Walgreens Boots Alliance has entered discussions regarding a potential sale to private equity firm Sycamore Partners, highlighting the increasing challenges confronting the retail pharmacy sector. The
The pharmaceutical industry has witnessed a dramatic decline in deal activity, reaching its lowest point in nearly a decade as major drugmakers pivot away from commercially ready medicines towards early-stage
AstraZeneca’s chief executive, Sir Pascal Soriot, has disclosed that former employees in China breached company protocols by using WeChat messaging services, amidst ongoing investigations by Chinese authorities. The revelation comes
Danish pharmaceutical giant Novo Nordisk has reported exceptional third-quarter results, driven by remarkable sales of its weight-loss treatment Wegovy. The anti-obesity medication generated sales of 17.3 billion Danish krone (£1.96
Senior NHS consultants are commanding extraordinary overtime payments of up to £200,000 annually as part of initiatives to reduce mounting waiting lists, according to recent revelations from BBC News. The
Recent breakthrough research from Denmark’s Aarhus University has sparked significant market interest in the pharmaceutical sector, particularly concerning exercise mimetics. The discovery of LaKe, a compound purported to replicate the
A concerning trend in cancer diagnoses among young adults has sparked a significant £20 million global research initiative. Data from the UK reveals cancer cases in individuals under 50 are
Growing concerns over potential staff shortages in Britain’s education and healthcare sectors have emerged following the Shadow Chancellor Rachel Reeves’ announcement of a stringent approach to public sector pay. The
A revolutionary combination of three drugs has demonstrated remarkable success in doubling survival times for patients battling incurable breast cancer, according to a landmark clinical trial. The research, spearheaded by






